Famotidine Powder, For Suspension
Product Images NDC 68475-400

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 68475-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (12419fdc 7a4c 4762 806c 0d56b478ef9d 01)

Figure (12419fdc 7a4c 4762 806c 0d56b478ef9d 01)
This text is a notice for the use of Famotidine oral suspension USP. It includes directions for storing and using the product, the inactive ingredients, dosage information, how to mix the solution, and the manufacturer's information. The product contains 400 mg of Famotidine, and each 5 mL contains 40 mg of Famotidine. The container should be kept tightly closed, and unused suspension should be discarded after 30 days. It is not available if the text in the unvarnished area contains important information.*
FDA Label Image

Image (12419fdc 7a4c 4762 806c 0d56b478ef9d 207 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.